These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 24504483)

  • 1. MicroRNA‑122 regulation of the morphology and cytoarchitecture of hepatoma carcinoma cells.
    Jin JC; Zhang X; Jin XL; Qian CS; Jiang H; Ruan Y
    Mol Med Rep; 2014 Apr; 9(4):1376-80. PubMed ID: 24504483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
    Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
    Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development.
    Shigoka M; Tsuchida A; Matsudo T; Nagakawa Y; Saito H; Suzuki Y; Aoki T; Murakami Y; Toyoda H; Kumada T; Bartenschlager R; Kato N; Ikeda M; Takashina T; Tanaka M; Suzuki R; Oikawa K; Takanashi M; Kuroda M
    Pathol Int; 2010 May; 60(5):351-7. PubMed ID: 20518884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
    Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
    Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.
    Zhang Y; Zheng D; Xiong Y; Xue C; Chen G; Yan B; Ye Q
    FEBS Lett; 2014 May; 588(10):1913-20. PubMed ID: 24704686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics analysis of gene expression alterations in microRNA‑122 knockout mice with hepatocellular carcinoma.
    He B; He Y; Shi W; Gong S; Chen X; Xiao J; Gu J; Ding W; Wang Y
    Mol Med Rep; 2017 Jun; 15(6):3681-3689. PubMed ID: 28393247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4.
    Cui M; Xiao Z; Sun B; Wang Y; Zheng M; Ye L; Zhang X
    Biochem Biophys Res Commun; 2014 Mar; 445(3):651-5. PubMed ID: 24576478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.
    Gu W; Li X; Wang J
    Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
    Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
    J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].
    Fu XY; Tan DM; Hou ZH; Hu ZL; Liu GZ; Ouyang Y; Liu F
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):598-604. PubMed ID: 23207154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma.
    Shimizu S; Takehara T; Hikita H; Kodama T; Miyagi T; Hosui A; Tatsumi T; Ishida H; Noda T; Nagano H; Doki Y; Mori M; Hayashi N
    J Hepatol; 2010 May; 52(5):698-704. PubMed ID: 20347499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship between microRNA-18 and BTG2 in the carcinogenesis of hepatocellular carcinoma].
    Li Q; Wang G; Zhang ZM
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):42-5. PubMed ID: 19203451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.
    Su H; Yang JR; Xu T; Huang J; Xu L; Yuan Y; Zhuang SM
    Cancer Res; 2009 Feb; 69(3):1135-42. PubMed ID: 19155302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells.
    Lin YH; Liao CJ; Huang YH; Wu MH; Chi HC; Wu SM; Chen CY; Tseng YH; Tsai CY; Chung IH; Wu TI; Tsai MM; Lin CD; Lin KH
    Oncogene; 2013 Sep; 32(38):4509-18. PubMed ID: 23912452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
    Cui M; Wang Y; Sun B; Xiao Z; Ye L; Zhang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):270-5. PubMed ID: 24462768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid hormone regulation of miR-21 enhances migration and invasion of hepatoma.
    Huang YH; Lin YH; Chi HC; Liao CH; Liao CJ; Wu SM; Chen CY; Tseng YH; Tsai CY; Lin SY; Hung YT; Wang CJ; Lin CD; Lin KH
    Cancer Res; 2013 Apr; 73(8):2505-17. PubMed ID: 23442323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MiR-122 regulates the expression of PEG10 in hepatoma cell lines].
    Chang Y; He XX; Li PY; Lin JS
    Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):288-91. PubMed ID: 20460050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling.
    Wang Y; Hu C; Cheng J; Chen B; Ke Q; Lv Z; Wu J; Zhou Y
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1255-60. PubMed ID: 24690171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.